These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28923653)

  • 21. A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes.
    Katsume A; Tokunaga Y; Hirata Y; Munakata T; Saito M; Hayashi H; Okamoto K; Ohmori Y; Kusanagi I; Fujiwara S; Tsukuda T; Aoki Y; Klumpp K; Tsukiyama-Kohara K; El-Gohary A; Sudoh M; Kohara M
    Gastroenterology; 2013 Oct; 145(4):865-73. PubMed ID: 23791700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy.
    Hanouneh IA; Miller C; Aucejo F; Lopez R; Quinn MK; Zein NN
    Liver Transpl; 2008 Jan; 14(1):53-8. PubMed ID: 18161839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and outcomes of HCV genotype-1-infected patients treated with peginterferon and ribavirin combination therapy with discordant HCV responses 4 and 12 weeks after starting therapy.
    Toyoda H; Kumada T; Shimada N; Takaguchi K; Ide T; Sata M; Ginba H; Matsuyama K; Izumi N
    Intervirology; 2014; 57(5):289-96. PubMed ID: 24992890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection.
    Sarrazin C; Mihm U; Herrmann E; Welsch C; Albrecht M; Sarrazin U; Traver S; Lengauer T; Zeuzem S
    J Infect Dis; 2005 Nov; 192(10):1710-9. PubMed ID: 16235168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical Characterization and In Vivo Efficacy of GSK8853, a Small-Molecule Inhibitor of the Hepatitis C Virus NS4B Protein.
    Pouliot JJ; Thomson M; Xie M; Horton J; Johnson J; Krull D; Mathis A; Morikawa Y; Parks D; Peterson R; Shimada T; Thomas E; Vamathevan J; Van Horn S; Xiong Z; Hamatake R; Peat AJ
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6539-50. PubMed ID: 26259798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Mammalian Target of Rapamycin Inhibition on Activated Regulatory T-Cell Expansion in Kidney Transplantation.
    Tomita Y; Uehara S; Takiguchi S; Nakamura M
    Transplant Proc; 2023 May; 55(4):792-796. PubMed ID: 37100735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus genotypes and the influence of the induction of immunosuppression with anti-thymocyte globulin (ATG) on chronic hepatitis in renal graft recipients.
    Rodrigues A; Pinho L; Lobato L; Queirós A; Castro R; Daniel M; Dias L; Henriques AC; Sarmento A; Guimarães S
    Transpl Int; 1998; 11 Suppl 1():S115-8. PubMed ID: 9664959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis c virus genotype 4 replication in the hepatocellular carcinoma cell line HepG2/C3A.
    Shier MK; El-Wetidy MS; Ali HH; Al-Qattan MM
    Saudi J Gastroenterol; 2016; 22(3):240-8. PubMed ID: 27184644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model.
    Umehara T; Sudoh M; Yasui F; Matsuda C; Hayashi Y; Chayama K; Kohara M
    Biochem Biophys Res Commun; 2006 Jul; 346(1):67-73. PubMed ID: 16750511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways.
    Trujillo-Murillo K; Rincón-Sánchez AR; Martínez-Rodríguez H; Bosques-Padilla F; Ramos-Jiménez J; Barrera-Saldaña HA; Rojkind M; Rivas-Estilla AM
    Hepatology; 2008 May; 47(5):1462-72. PubMed ID: 18393288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arsenic trioxide inhibits hepatitis C virus RNA replication through modulation of the glutathione redox system and oxidative stress.
    Kuroki M; Ariumi Y; Ikeda M; Dansako H; Wakita T; Kato N
    J Virol; 2009 Mar; 83(5):2338-48. PubMed ID: 19109388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.
    De Simone P; Fagiuoli S; Cescon M; De Carlis L; Tisone G; Volpes R; Cillo U;
    Transplantation; 2017 Feb; 101(2):239-251. PubMed ID: 27495768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins.
    Nakagawa M; Sakamoto N; Tanabe Y; Koyama T; Itsui Y; Takeda Y; Chen CH; Kakinuma S; Oooka S; Maekawa S; Enomoto N; Watanabe M
    Gastroenterology; 2005 Sep; 129(3):1031-41. PubMed ID: 16143140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
    Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
    Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the inhibition of hepatitis C virus entry by in vitro-generated and patient-derived oxidized low-density lipoprotein.
    Westhaus S; Bankwitz D; Ernst S; Rohrmann K; Wappler I; Agné C; Luchtefeld M; Schieffer B; Sarrazin C; Manns MP; Pietschmann T; Ciesek S; von Hahn T
    Hepatology; 2013 May; 57(5):1716-24. PubMed ID: 23212706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of steroids on hepatitis C virus replication in vivo and in vitro.
    Henry SD; Metselaar HJ; Van Dijck J; Tilanus HW; Van Der Laan LJ
    Ann N Y Acad Sci; 2007 Sep; 1110():439-47. PubMed ID: 17911459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders.
    Uemura H; Tsukada K; Mizushima D; Aoki T; Watanabe K; Kinai E; Teruya K; Gatanaga H; Kikuchi Y; Sugiyama M; Mizokami M; Oka S
    PLoS One; 2017; 12(10):e0186255. PubMed ID: 29045448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between hepatitis C virus replication and CXCL-8 production in vitro.
    Koo BC; McPoland P; Wagoner JP; Kane OJ; Lohmann V; Polyak SJ
    J Virol; 2006 Aug; 80(16):7885-93. PubMed ID: 16873245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of short RNA structural analogues against hepatitis C virus genotypes 2, 3 and 4 in replicon cells.
    Elshaffei IM; Gupta N; Wu CH; Wu DC; Hammad LN; Abo-Elmatty DM; Mesbah NM; Wu GY
    J Dig Dis; 2015 Aug; 16(8):449-55. PubMed ID: 25873200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.